GNTLF Shariah Compliance
Screening Methodology: AAOIFI
LOCKED
Genetic Technologies Ltd. Stock Analysis GNTLF
United States Health Care Nano Cap Genetic Technologies Ltd. engages in the provision of molecular risk assessment tests for cancer. The company is headquartered in Melbourne, Victoria and currently employs 58 full-time employees. The firm is engaged in providing genomics-based tests on health, wellness and serious disease through its EasyDNA brand. The firm offers cancer predictive testing and assessment tools to help physicians to improve health outcomes for people around the world. The firm has a proprietary risk stratification platform that integrates clinical and genetic risk to deliver outcomes to physicians and individuals. The firm's segments include EasyDNA and AffinityDNA. EasyDNA segment relates to EasyDNA branded test sales and expenses. AffinityDNA segment relates to AffinityDNA branded test sales and expenses.
Read More GNTLF Chart
Genetic Technologies Ltd vs S&P/ASX 200 Comparative Returns
Analysis of GNTLF stock performance compared to the broader market (S&P/ASX 200) across multiple timeframes.
YTD Performance
- Genetic Technol... (GNT...) 1328.57%
- S&P/ASX 200 4.2%
Genetic Technol... Outperformed S&P/ASX 200 by 1324.37%
1Y Performance
- Genetic Technol... (GNT...) 1328.57%
- S&P/ASX 200 9.24%
Genetic Technol... Outperformed S&P/ASX 200 by 1319.33%
3Y Performance
- Genetic Technol... (GNT...) 400%
- S&P/ASX 200 27.09%
Genetic Technol... Outperformed S&P/ASX 200 by 372.91%
5Y Performance
- Genetic Technol... (GNT...) %
- S&P/ASX 200 46.27%
Genetic Technol... Underperformed S&P/ASX 200 by N/A%
FAQ's
Halal stocks refer to shares of companies that comply with Islamic finance principles, meaning they do not engage in businesses related to alcohol, gambling, pork, or interest-based financial services.
